The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The carbon tetrachloride model in mice
Open accessAbstract
Recently, the need for more standardized operation procedures in experimental liver fibrosis research was suggested due to dramatic changes in European animal welfare rules. Here, we present a short series of standard operation procedures (SOPs) summarizing the most relevant and widely accepted experimental models for the induction of liver injury leading to liver fibrosis. The described procedures are based on the long-term experience of the Collaborative Research Centre ‘Organ Fibrosis: From Mechanisms of Injury to Modulation of Disease’ ( http://www.sfbtrr57.rwth-aachen.de/ ), which is supported by the German Research Foundation (SFB/TRR57). These SOPs will help to improve standardization of fibrosis models and to increase the comparability of data between different laboratories with the aim of reducing animal experimentation according to the principle that was proposed in 1959 by Russell and Burch as an ethical framework for conducting scientific experiments with animals, namely the replacement, refinement and reduction (3R) principle. In the first section we focus on the carbon tetrachloride (CCl 4) model in mice, which is the toxic model of liver fibrosis induction most commonly used worldwide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971
The Principles of Humane Experimental Technique
(1960) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1960.tb73127.x · Cited by 4,912
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model
Weber, L. W. D., Boll, M., & Stampfl, A. (2003) · Critical Reviews in Toxicology · doi:10.1080/713611034 · Cited by 1,777
CCR2 promotes hepatic fibrosis in mice #
Seki, E., de Minicis, S., Inokuchi, S., Taura, K., Miyai, K., van Rooijen, N., Schwabe, R. F., & Brenner, D. A. (2009) · Hepatology · doi:10.1002/hep.22952 · Cited by 416
Liedtke, C., Luedde, T., Sauerbruch, T., Scholten, D., Streetz, K., Tacke, F., Tolba, R., Trautwein, C., Trebicka, J., & Weiskirchen, R. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-19 · Cited by 335
Self-citationShi, Z., Wakil, A. E., & Rockey, D. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10663 · Cited by 310
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans
Hillebrandt, S., Wasmuth, H. E., Weiskirchen, R., Hellerbrand, C., Keppeler, H., Werth, A., Schirin-Sokhan, R., Wilkens, G., Geier, A., Lorenzen, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1599 · Cited by 258
Self-citationModeling Liver Fibrosis in Rodents
Constandinou, C., Henderson, N., & Iredale, J. P. (2005) · Fibrosis Research · doi:10.1385/1-59259-940-0:237 · Cited by 247
Fujii, T., Fuchs, B. C., Yamada, S., Lauwers, G. Y., Kulu, Y., Goodwin, J. M., Lanuti, M., & Tanabe, K. K. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-79 · Cited by 202
CXC chemokine ligand 4 (Cxcl4) is a platelet‐derived mediator of experimental liver fibrosis†
Zaldivar, M. M., Pauels, K., von Hundelshausen, P., Berres, M., Schmitz, P., Bornemann, J., Kowalska, M. A., Gassler, N., Streetz, K. L., Weiskirchen, R., et al. (2010) · Hepatology · doi:10.1002/hep.23435 · Cited by 171
Self-citationAntifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and Humans
Wasmuth, H. E., Lammert, F., Zaldivar, M. M., Weiskirchen, R., Hellerbrand, C., Scholten, D., Berres, M.-L., Zimmermann, H., Streetz, K. L., Tacke, F., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.053 · Cited by 168
Self-citationThe role of mouse strain differences in the susceptibility to fibrosis: a systematic review
Walkin, L., Herrick, S. E., Summers, A., Brenchley, P. E., Hoff, C. M., Korstanje, R., & Margetts, P. J. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-18 · Cited by 160
Borkham‐Kamphorst, E., de Leur, E. V., Zimmermann, H. W., Karlmark, K. R., Tihaa, L., Haas, U., Tacke, F., Berger, T., Mak, T. W., & Weiskirchen, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.014 · Cited by 146
Self-citationA novel model of CCl4-induced cirrhosis with ascites in the mouse
Domenicali, M., Caraceni, P., Giannone, F. A., Baldassarre, M., Lucchetti, G., Quarta, C., Patti, C., Catani, L., Nanni, C., Lemoli, R. M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.09.008 · Cited by 133
Angiotensin-II Type 1 Receptor-Mediated Janus Kinase 2 Activation Induces Liver Fibrosis
Granzow, M., Schierwagen, R., Klein, S., Kowallick, B., Huss, S., Linhart, M., Mazar, I. G. R., Görtzen, J., Vogt, A., Schildberg, F. A., et al. (2014) · Hepatology · doi:10.1002/hep.27117 · Cited by 131
Self-citationHillebrandt, S., Goos, C., Matern, S., & Lammert, F. (2002) · Gastroenterology · doi:10.1053/gast.2002.37069 · Cited by 104
Sensitivity of several serum enzymes in detecting carbon tetrachloride-induced liver damage in rats
Korsrud, G. O., Grice, H. C., & McLaughlan, J. M. (1972) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(72)90255-4 · Cited by 97
Chang, M. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i27.4167 · Cited by 68
Strain differences in mice in carbon tetrachloride-induced liver injury.
Bhathal, P. S., Rose, N. R., Mackay, I. R., & Whittingham, S. (1983) · PubMed · Cited by 64
Nevzorova, Y. A., Bangen, J., Hu, W., Haas, U., Weiskirchen, R., Gaßler, N., Huss, S., Tacke, F., Siciński, P., Trautwein, C., et al. (2012) · Hepatology · doi:10.1002/hep.25736 · Cited by 64
Self-citationLiu, Y., Lui, E. L. H., Friedman, S. L., Li, L., Ye, T., Chen, Y., Poon, R. T. P., Wo, J. Y. H., Kok, T. W., & Fan, S. T. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.127 · Cited by 37
Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice
Huss, S., Stellmacher, C., Goltz, D., Khlistunova, I., Adam, A. C., Trebicka, J., Kirfel, J., Büttner, R., & Weiskirchen, R. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-8 · Cited by 12
Self-citation
Cited by
Diversity and biology of cancer-associated fibroblasts
Biffi, G., & Tuveson, D. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00048.2019 · Cited by 1,265
Tsuchida, T., Lee, Y. A., Fujiwara, N., Ybanez, M., Allen, B., Martins, S., Fiel, M. I., Goossens, N., Chou, H.-I., Hoshida, Y., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.011 · Cited by 583
Experimental models of liver fibrosis
Crespo Yanguas, S., Cogliati, B., Willebrords, J., Maes, M., Colle, I., van den Bossche, B., de Oliveira, C. P. M. S., Andraus, W., Alves, V. A., Leclercq, I., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1543-4 · Cited by 350
Toxicity of carbon tetrachloride, free radicals and role of antioxidants
Unsal, V., Cicek, M., & Sabancilar, İ. (2021) · Reviews on Environmental Health · doi:10.1515/reveh-2020-0048 · Cited by 320
Liver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Metadata
- Authors
- Scholten, D., Trebicka, J., Liedtke, C., & Weiskirchen, R.
- Venue
- Laboratory Animals
- Publisher
- SAGE Publications
- Published
- 2015-04
- Volume
- 49
- Issue
- 1_suppl
- Pages
- 4-11
- ISSN
- 0023-6772 (ISSN-L)
- 1758-1117
- OpenAlex
- W2111199541
- Cited by
- 414
- References
- 23
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.